Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for reducing bleeding and oxytocin use during elective cesarean section
IRCT20170314033069N3Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine in postpartum hemorrhage (PPH) (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: Bleeding rate, Oxytocin consumption and 1 more. Started Dec 2020; status: completed.
02
Drugs
ketamine
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on IRCT20170314033069N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170314033069N3.